DA
Dana Aftab (EVP, Research and Development) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Exelixis, Inc. (EXEL). The largest single filing was $2.2M of EXEL (43,451 sh × $50.35, as filed), executed May 26. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
4
0 buys · 4 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$5.6M
shares × price, as filed
Last traded
May 26
Filed May 28
Median ADV $143.0M across their filed names
Open performance→Volume by month
Buys $0
Sells $8.7M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
4 filings
Sector per market data · by filing · past 12 months
Most traded names
EXEL
Exelixis, Inc.
EXEL · 0 buys · 5 sells
5 filings
Recent filings
EXELSALE
Exelixis, Inc.
View filing →
$2.2M43,451 sh × $50.35
Exec May 26
Filed May 28 · 5:30 PM ET EXELSALE Exelixis, Inc. View filing → $2.1M
47,918 sh × $44.50
Exec Feb 24
Filed Feb 26 · 5:30 PM ET EXELSALE Exelixis, Inc. View filing → $1.3M
29,873 sh × $44.35
Exec Feb 19
Filed Feb 23 · 5:30 PM ET EXELSALE Exelixis, Inc. View filing → $2.1M
48,383 sh × $42.50
Exec Nov 11 2025
Filed Nov 13 2025 · 5:30 PM ET EXELSALE Exelixis, Inc. View filing → $992K
26,987 sh × $36.75
Exec Feb 24 2025
Filed Feb 26 2025 · 5:30 PM ET EXELSALE Exelixis, Inc. View filing → $3.4M
96,986 sh × $35.00
Exec Nov 5 2024
Filed Nov 7 2024 · 5:30 PM ET